These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 20495663)

  • 1. Peptide-based Antifungal Therapies against Emerging Infections.
    Matejuk A; Leng Q; Begum MD; Woodle MC; Scaria P; Chou ST; Mixson AJ
    Drugs Future; 2010 Mar; 35(3):197. PubMed ID: 20495663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane transporters and antifungal drug resistance.
    St Georgiev V
    Curr Drug Targets; 2000 Nov; 1(3):261-84. PubMed ID: 11465075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antifungal agents.
    Gupta AK; Tomas E
    Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
    Di Mambro T; Guerriero I; Aurisicchio L; Magnani M; Marra E
    Front Pharmacol; 2019; 10():80. PubMed ID: 30804788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis.
    Scorzoni L; de Paula E Silva AC; Marcos CM; Assato PA; de Melo WC; de Oliveira HC; Costa-Orlandi CB; Mendes-Giannini MJ; Fusco-Almeida AM
    Front Microbiol; 2017; 8():36. PubMed ID: 28167935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal Activity, Toxicity, and Membranolytic Action of a Mastoparan Analog Peptide.
    Singulani JL; Galeane MC; Ramos MD; Gomes PC; Dos Santos CT; de Souza BM; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
    Front Cell Infect Microbiol; 2019; 9():419. PubMed ID: 31867293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
    Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
    Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges.
    Ademe M
    Front Cell Infect Microbiol; 2020; 10():469. PubMed ID: 33042859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic
    Revie NM; Robbins N; Whitesell L; Frost JR; Appavoo SD; Yudin AK; Cowen LE
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
    Groll AH; Walsh TJ
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to antifungal therapies.
    Prasad R; Banerjee A; Shah AH
    Essays Biochem; 2017 Feb; 61(1):157-166. PubMed ID: 28258238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral mycoses and other opportunistic infections in HIV: therapy and emerging problems - a workshop report.
    Vidya KM; Rao UK; Nittayananta W; Liu H; Owotade FJ
    Oral Dis; 2016 Apr; 22 Suppl 1():158-65. PubMed ID: 27109283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungals.
    Campoy S; Adrio JL
    Biochem Pharmacol; 2017 Jun; 133():86-96. PubMed ID: 27884742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity.
    Wall G; Lopez-Ribot JL
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy.
    Wall G; Lopez-Ribot JL
    Antibiotics (Basel); 2020 Jul; 9(8):. PubMed ID: 32722455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development.
    Ablordeppey SY; Fan P; Ablordeppey JH; Mardenborough L
    Curr Med Chem; 1999 Dec; 6(12):1151-95. PubMed ID: 10519919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Future of Antifungal Drug Therapy: Novel Compounds and Targets.
    Mota Fernandes C; Dasilva D; Haranahalli K; McCarthy JB; Mallamo J; Ojima I; Del Poeta M
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reinforcing the Immunocompromised Host Defense against Fungi: Progress beyond the Current State of the Art.
    Karavalakis G; Yannaki E; Papadopoulou A
    J Fungi (Basel); 2021 Jun; 7(6):. PubMed ID: 34204025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in antifungal prevention and treatment.
    Groll AH; Tragiannidis A
    Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.